Clinical Trials Browser

Withdrawn × Imatinib Mesylate × Dermatologic × Clear all

NCT02812693 2018-04-05

Pembrolizumab and Imatinib in Patients With Locally Advanced/Metastatic Melanoma With c-KIT Mutation/Amplification

Phase 1/2 Withdrawn

Melanoma